FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Thread starter International: Top News And Analysis
Start date Mar 18, 2026

International: Top News And Analysis

Guest

Mar 18, 2026

Johnson & Johnson said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Prefix: N/A

Forum: World News

Start date: Mar 18, 2026

Last reply date: Mar 18, 2026

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Mar 18, 2026

Replies: 0

Views: 4

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search